• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease.

作者信息

Armstrong David

机构信息

Douglas Family Chair in Nutrition Research Farncombe Family Digestive Health Research Institute & Division of Gastroenterology McMaster University Hamilton, Ontario, Canada.

出版信息

Gastroenterol Hepatol (N Y). 2023 May;19(5):295-298.

PMID:37799455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10548244/
Abstract
摘要

相似文献

1
Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease.钾离子竞争性酸阻滞剂与胃食管反流病
Gastroenterol Hepatol (N Y). 2023 May;19(5):295-298.
2
Potassium-competitive acid blockers and gastroesophageal reflux disease.钾离子竞争型酸阻断剂与胃食管反流病。
World J Gastroenterol. 2022 Jul 28;28(28):3608-3619. doi: 10.3748/wjg.v28.i28.3608.
3
The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.钾离子竞争型酸阻滞剂在胃食管反流病治疗中的潜在作用。
Curr Opin Gastroenterol. 2019 Jul;35(4):344-355. doi: 10.1097/MOG.0000000000000543.
4
Tegoprazan to treat gastroesophageal reflux disease.替戈拉赞治疗胃食管反流病。
Drugs Today (Barc). 2020 Nov;56(11):715-721. doi: 10.1358/dot.2020.56.11.3202811.
5
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).胃食管反流病（GERD）的药物治疗管理
Expert Opin Pharmacother. 2021 Feb;22(2):219-227. doi: 10.1080/14656566.2020.1817385. Epub 2020 Sep 7.
6
[Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers].使用钾离子竞争性酸阻滞剂治疗酸相关性疾病
Korean J Gastroenterol. 2022 Dec 25;80(6):247-253. doi: 10.4166/kjg.2022.143.
7
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.当今的十二指肠溃疡与胃食管反流病：长期治疗——侧面审视
Yale J Biol Med. 1996 May-Jun;69(3):211-24.
8
Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?钾离子竞争性酸阻滞剂——它们会是下一代质子泵抑制剂吗？
World J Gastrointest Pharmacol Ther. 2018 Dec 13;9(7):63-68. doi: 10.4292/wjgpt.v9.i7.63.
9
New and future drug development for gastroesophageal reflux disease.胃食管反流病的新型及未来药物研发
J Neurogastroenterol Motil. 2014 Jan;20(1):6-16. doi: 10.5056/jnm.2014.20.1.6. Epub 2013 Dec 30.
10
Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.钾离子竞争型酸阻滞剂：酸相关疾病的先进治疗选择。
Pharmacol Ther. 2016 Dec;168:12-22. doi: 10.1016/j.pharmthera.2016.08.001. Epub 2016 Aug 8.

引用本文的文献

1
Comparison of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.钾离子竞争性酸阻滞剂与质子泵抑制剂治疗胃食管反流病患者的比较：一项随机对照试验的系统评价和荟萃分析
Cureus. 2024 Jul 22;16(7):e65141. doi: 10.7759/cureus.65141. eCollection 2024 Jul.
2
Chitosan Nanoparticles for Gastroesophageal Reflux Disease Treatment.用于治疗胃食管反流病的壳聚糖纳米颗粒
Polymers (Basel). 2023 Aug 20;15(16):3485. doi: 10.3390/polym15163485.

本文引用的文献

1
Potassium-Competitive Acid Blockers: Present and Potential Utility in the Armamentarium for Acid Peptic Disorders.钾离子竞争性酸阻滞剂：在酸相关性疾病治疗药物中的现状与潜在应用价值
Gastroenterol Hepatol (N Y). 2022 Dec;18(12):693-700.
2
Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.Vonoprazan 与兰索拉唑治疗糜烂性食管炎的愈合和维持愈合：一项随机试验。
Gastroenterology. 2023 Jan;164(1):61-71. doi: 10.1053/j.gastro.2022.09.041. Epub 2022 Oct 10.
3
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染：随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
4
Knowledge gaps in the management of refractory reflux-like symptoms: Healthcare provider survey.难治性反流样症状管理中的知识差距：医疗保健提供者调查。
Neurogastroenterol Motil. 2022 Oct;34(10):e14387. doi: 10.1111/nmo.14387. Epub 2022 May 3.
5
Thailand guideline 2020 for medical management of gastroesophageal reflux disease.泰国 2020 年胃食管反流病医学管理指南。
J Gastroenterol Hepatol. 2022 Apr;37(4):632-643. doi: 10.1111/jgh.15758. Epub 2022 Jan 25.
6
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.美国胃肠病学会胃食管反流病诊断和管理临床指南
Am J Gastroenterol. 2022 Jan 1;117(1):27-56. doi: 10.14309/ajg.0000000000001538.
7
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990 年至 2017 年全球 195 个国家和地区胃食管反流病的全球、区域和国家负担：2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):561-581. doi: 10.1016/S2468-1253(19)30408-X. Epub 2020 Mar 13.
8
Modern diagnosis of GERD: the Lyon Consensus.现代 GERD 诊断：里昂共识。
Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Epub 2018 Feb 3.
9
World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease.世界胃肠病学组织全球指南：胃食管反流病的全球视角
J Clin Gastroenterol. 2017 Jul;51(6):467-478. doi: 10.1097/MCG.0000000000000854.